Add |
# |
ItemCode |
Item Name |
Unit |
Dosage form/Strength |
Pack Size |
In Basic EDL (District) |
In Basic EDL (State) |
Annual Requirements |
Item Category |
SubCategory |
EssentialType |
MeasurementType |
Volume per qty |
|
|
1 |
1403 |
Tacrolimus |
Tube |
Oint 0.1% |
10 gm Tube |
|
|
0 |
Drugs |
General Drugs |
|
|
|
|
|
2 |
1402 |
Tacrolimus |
Tube |
Oint .03% |
10 gm Tube |
|
|
0 |
Drugs |
General Drugs |
|
|
|
|
|
3 |
1401 |
Tacrolimus |
Capsule |
Cap 0.5mg |
1x10 |
|
|
1000 |
Drugs |
Specialty Drugs |
|
Not Applicable |
0 |
|
|
4 |
1400 |
Tacrolimus |
Capsule |
Cap 1mg |
1x10 |
|
|
500 |
Drugs |
Specialty Drugs |
|
Not Applicable |
0 |
|
|
5 |
1399 |
Surfactant(Bovine Lipid extract) |
Vial |
Phospholipid content 27mg/ml |
5 ml Vial |
|
|
20 |
Drugs |
General Drugs |
|
|
|
|
|
6 |
1398 |
Sunitinib |
Tablet |
Tablet 12.5mg |
1x7 |
|
|
112 |
Drugs |
Specialty Drugs |
|
Not Applicable |
0 |
|
|
7 |
1397 |
Sulfasalazine |
Tablet |
Tablet 500 mg |
1x10 |
|
|
600 |
Drugs |
General Drugs |
|
|
|
|
|
8 |
1396 |
Sucralfate |
Bottle |
Oral liquid 1 gm/5 ml |
100 ml Bottle with measuring cap |
|
|
400 |
Drugs |
General Drugs |
|
|
|
|
|
9 |
1395 |
Succinylcholine |
Vial |
Injection 50 mg/ml |
10 ml Vial |
|
|
100 |
Drugs |
General Drugs |
|
|
|
|
|
10 |
1394 |
Streptokinase |
Vial |
Injection 15,00,000 IU |
Vial |
|
|
0 |
Drugs |
Specialty Drugs |
|
Not Applicable |
0 |
|
|
11 |
1393 |
Streptokinase |
Vial |
Injection 750,000 IU |
Vial |
|
|
0 |
Drugs |
Specialty Drugs |
|
Not Applicable |
0 |
|
|
12 |
1392 |
Spironolactone |
Tablet |
Tablet 25 mg |
1X10 |
|
|
400 |
Drugs |
General Drugs |
|
|
|
|
|
13 |
1391 |
Sorafinib |
Tablet |
Tab 200mg |
120 Tablets in a bottle |
|
|
0 |
Drugs |
Specialty Drugs |
|
Not Applicable |
0 |
|
|
14 |
1390 |
Somatostatin |
Vial |
Powder for Injection 3 mg |
Vial |
|
|
0 |
Drugs |
General Drugs |
|
|
|
|
|
15 |
1389 |
Sofosbuvir |
Tablet |
Tablet 400 mg |
1x28 |
|
|
1624 |
Drugs |
Specialty Drugs |
|
Not Applicable |
0 |
|
|
16 |
1388 |
Sodium valproate |
Vial |
Injection 100 mg/ml |
5 ml Vial |
|
|
0 |
Drugs |
General Drugs |
|
|
|
|
|
17 |
1387 |
Sodium valproate |
Bottle |
Oral liquid 200 mg/5ml |
100 ml Bottle with measuring cap |
|
|
0 |
Drugs |
General Drugs |
|
|
|
|
|
18 |
1386 |
Sodium valproate |
Tablet |
Tablet 200 mg |
1X10 |
|
|
600 |
Drugs |
General Drugs |
|
|
|
|
|
19 |
1385 |
Sodium Nitroprusside |
Vial |
Injection 50 mg |
Vial |
|
|
0 |
Drugs |
General Drugs |
|
|
|
|
|
20 |
1384 |
Sodium Hypochloride Solution |
Bottle |
As per lisenced |
500 ml bottle |
|
|
0 |
Drugs |
General Drugs |
|
|
|
|
|
21 |
1383 |
Sodium chloride |
FFS Bottle |
Injection 0.9% |
500 ml FFS Plastic Bottle |
|
|
3000 |
Drugs |
General Drugs |
|
|
|
|
|
22 |
1382 |
Sodium bicarbonate |
Vial |
Injection 8.4% w/v |
10 ml Vial |
|
|
0 |
Drugs |
General Drugs |
|
|
|
|
|
23 |
1381 |
Snake venom antiserum lyophilized polyvalent |
Vial |
Powder for Injection |
Vial with 10 ml sterile water for injection for re |
|
|
100 |
Drugs |
General Drugs |
|
|
|
|
|
24 |
1380 |
Silver Sulphadiazine |
Tube |
Cream 1% |
30 gm Tube |
|
|
300 |
Drugs |
General Drugs |
|
|
|
|
|
25 |
1379 |
Sevoflurane |
Bottle |
Inhalation |
250 ml Bottle |
|
|
12 |
Drugs |
General Drugs |
|
|
|
|
|
26 |
1378 |
Salicylic acid |
Tube |
Ointment 6% |
30 gm Tube |
|
|
100 |
Drugs |
General Drugs |
|
|
|
|
|
27 |
1377 |
Salbutamol |
Bottle |
Respirator solution for use in nebulizer 5mg/ml |
15 ml Bottle |
|
|
500 |
Drugs |
General Drugs |
|
|
|
|
|
28 |
1376 |
Salbutamol |
Inhaler |
Inhalation (MDI/DPI) 100 mcg/dose. |
200 Meter Dose |
|
|
150 |
Drugs |
General Drugs |
|
|
|
|
|
29 |
1375 |
Salbutamol |
Bottle |
Oral liquid 2 mg/5 ml |
100 ml Bottle with measuring cap |
|
|
100 |
Drugs |
General Drugs |
|
|
|
|
|
30 |
1374 |
Salbutamol |
Tablet |
Tablet 4 mg |
1X10 |
|
|
1500 |
Drugs |
General Drugs |
|
|
|
|
|
31 |
1373 |
Ruxolitinib |
Tablet |
Tablet 20 mg |
1x14 |
|
|
3108 |
Drugs |
Specialty Drugs |
|
Not Applicable |
0 |
|
|
32 |
1372 |
Rituximab |
Vial |
Inj 500mg |
Vial |
|
|
160 |
Drugs |
Specialty Drugs |
|
Not Applicable |
0 |
|
|
33 |
1371 |
Ringer lactate |
FFS Bottle |
Injection (as per IP) |
500 ml FFS Plastic Bottle |
|
|
1008 |
Drugs |
General Drugs |
|
|
|
|
|
34 |
1370 |
Riboflavin |
Tablet |
Tablet 5 mg |
1X10 |
|
|
3000 |
Drugs |
General Drugs |
|
|
|
|
|
35 |
1369 |
Ribavirin |
Capsule |
Capsule 200 mg |
1x4 |
|
|
0 |
Drugs |
Specialty Drugs |
|
Not Applicable |
0 |
|
|
36 |
1368 |
Ranitidine |
Amp |
Injection 25 mg/ml |
2 ml Amp |
|
|
400 |
Drugs |
General Drugs |
|
|
|
|
|
37 |
1367 |
Ranitidine |
Tablet |
Tablet 150 mg |
1X10 |
|
|
40000 |
Drugs |
General Drugs |
|
|
|
|
|
38 |
1366 |
Ramipril |
Tablet |
Tablet 5 mg |
1X10 |
|
|
200 |
Drugs |
General Drugs |
|
|
|
|
|
39 |
1365 |
Rabies vaccine |
Vial |
Injection 2.5 IU |
Vial with 1 ml sterile water for injection |
|
|
50 |
Drugs |
General Drugs |
|
|
|
|
|
40 |
1364 |
Quinine |
Amp |
Injection 300 mg/ml |
2 ml Amp |
|
|
0 |
Drugs |
General Drugs |
|
|
|
|
|
41 |
1363 |
Quinine |
Tablet |
Tablet 300 mg |
1X10 |
|
|
500 |
Drugs |
General Drugs |
|
|
|
|
|
42 |
1362 |
Protamine |
Amp |
Injection 10 mg/ml |
5 ml Amp |
|
|
0 |
Drugs |
General Drugs |
|
|
|
|
|
43 |
1361 |
Propranolol |
Tablet |
Tablet 40 mg |
1X10 |
|
|
3000 |
Drugs |
General Drugs |
|
|
|
|
|
44 |
1360 |
Propranolol |
Tablet |
Tablet 10 mg |
1X10 |
|
|
0 |
Drugs |
General Drugs |
|
|
|
|
|
45 |
1359 |
Propofol |
Amp |
Injection 10 mg/ml |
20 ml Amp |
|
|
100 |
Drugs |
General Drugs |
|
|
|
|
|
46 |
1358 |
Primaquine |
Tablet |
Tablet 7.5 mg |
1x10 |
|
|
300 |
Drugs |
General Drugs |
|
|
|
|
|
47 |
1357 |
Primaquine |
Tablet |
Tablet 2.5 mg |
1x10 |
|
|
300 |
Drugs |
General Drugs |
|
|
|
|
|
48 |
1356 |
Prilocaine (A) + Lignocaine (B) |
Tube |
Cream 2.5% (A) + 2.5% (B) |
30 gm Tube |
|
|
0 |
Drugs |
General Drugs |
|
|
|
|
|
49 |
1355 |
Premix Insulin 30:70 Injection (Regular:NPH) |
Vial |
Injection 40 IU/ml |
10 ml Vial |
|
|
30 |
Drugs |
General Drugs |
|
|
|
|
|
50 |
1354 |
Prednisolone |
Bottle |
Oral liquid 5 mg/5 ml |
60 ml Bottle with measuring cap |
|
|
0 |
Drugs |
General Drugs |
|
|
|
Add |
|
|
|
|
|
|
|
|
|
|
|
|
|
|